J. Jacobs

Impact of Angiotensin II Signaling Blockade on Clinical Outcomes in Patients with Inflammatory Bowel Disease

M. Bissonnette, Y. Li, J. Pekow, 2019, Digestive Diseases and Sciences.

Northern Latitude but Not Season Is Associated with Increased Rates of Hospitalizations Related to Inflammatory Bowel Disease: Results of a Multi-Year Analysis of a National Cohort

M. Bissonnette, J. Pekow, J. Gaetano, 2016, PloS one.

Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn's Disease.

K. Kamp, Scott D. Lee, A. Singla, 2021, Inflammatory bowel diseases.

Endoscopy for the Diagnosis of Inflammatory Bowel Disease

Scott D. Lee, J. Jacobs, S. Lee, 2018, Endoscopy - Novel Techniques and Recent Advancements.

Role of Cellular Heparan Sulfate Proteoglycans in Infection of Human Adenovirus Serotype 3 and 35

David F. Smith, S. Tuve, Hongjie Wang, 2008, PLoS pathogens.

Case Report of a SARS-CoV-2 Infection in a Patient With Ulcerative Colitis on Tofacitinib

Scott D. Lee, J. Jacobs, Kindra Clark‐Snustad, 2020, Inflammatory bowel diseases.

Perceptions of risk and therapy among patients with Barrett's esophagus: a patient survey study.

V. Konda, U. Siddiqui, I. Waxman, 2018, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

In situ adenovirus vaccination engages T effector cells against cancer.

Y. Liu, S. Tuve, S. Roffler, 2009, Vaccine.

Angiotensin II Blockade Is Associated With Worse Clinical Outcomes in IBD Patients: 1964

M. Bissonnette, Y. Li, J. Pekow, 2015 .